eamdacademy.org-VEpw-1793065114-u971098231 1793065114 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2023 2 2 Nattapong Srisawat Ploy Chantarangsu Kittipong Saengchai 2023 10.68159/u971098231 https://eamdacademy.org/pub/journal/3/article/u971098231 Kiani AA, Kazemi AR, Mahmoudvand H, Fathi N, Mahaki S, Ezzatkhah F. Prevalence and associated risk factors of soil-transmitted helminthic parasites in Iranian children with hypereosinophilia. Entomol Appl Sci Lett. 2020;7(2):20-5. Eltayeb LB, Al-Zahrani SA, Al-Hoechel LH, Ali H. Bacteriological and parasitological assessment of apparently healthy food handlers at Al-Kharj province/KSA: a cross-sectional prospective study. Int J Pharm Phytopharmacol Res. 2020;10(4):103-11. Ruban DI, Glamazdin IG, Udavliev DI, Mamedberdyeva MD, Stepanova SP, Bondarenko VO. Efficiency of antiparasiitic drug iverpradag in the treatment of parasitoses of horses. Russ J ProblVet Sanit, Hyg Ecol. 2018;(1):110-3. Melnis RI. Epizootological surveillance at endo and ectoparasitosis of chickens. Disser. 2017:66-70. Musaev MB, Shumakovich IE, Arkhipov IA, Abramov VE. A method of obtaining an agent for the treatment of one-hoofed animals with parasitosis. Patent for invention; 2019. Sinyakov MP. Development of a complex antiparasitic drug for horses and assessment of extensibility, scientific notes of an educational institution Badge of Honor of the State Academy of Veterinary Medicine. Sci Pract J Vitebsk. 2020;56(3):51-4. Saakova KA, Mirzoeva RK, Berdysh DS. Modern antihelminth preparations. Eurasian Union Scientists. 5(7(76)):51-4. Juarez M, Schcolnik-Cabrera A, Dueñas-Gonzalez A. The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. Am J Cancer Res. 2018;8(2):317-31. Petrov VV, Sinyakov MP, Solovieva AV. Toxicological characteristics of the veterinary preparation “Prazimax”. Vet J Belarus. 2020;1(12):72. Thomas CM, Timson DJ. The mechanism of action of praziquantel: can new drugs exploit similar mechanisms? Curr Med Chem. 2020;27(5):676-96. Babes RM, Selescu T, Domocos D, Babes A. The anthelminthic drug praziquantel is a selective agonist of the sensory transient receptor potential melastatin type 8 channel. Toxicol Appl Pharmacol. 2017;336:55-65. Rules of laboratory practice, Order of the Ministry of Health of the Russian Federation No. 708n dated 23 Aug 2010. Khabriev RU. Guidelines for experimental (preclinical) study of new pharmacological substances, under total. Corresponding member of the Russian Academy of Medical Sciences. 2012;1(1):45-7. Zolotarev YA, Dadayan AK, Kozik VS, Shram SI, Azev VN, Bogachouk AP, et al. Pharmacokinetics of HLDF-6-AA peptide in the organism of experimental animals. Russ J Bioorg Chem. 2019;45(6):514-21. European Convention for Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes (ETS 123). Strasbourg, 1986. Finney DJ. Probit analysis, Cambridge University Press. Cambridge, UK; 1971. 338 p. GOST 12.1.007-76. Occupational safety standards system. Harmful substances. Classification and general safety requirements (with Amendments N 1, 2). Severina HI, Skupa OO, Voloshchuk NI, Saidov N, Bunyatyan VA, Kovalenko SM, et al. Molecular docking, ADMET study and in vivo pharmacological research of N- (3,4-dimetoxyphenyl)-2-{[ 2-methyl-6-(pyridine-2-yl)-pyrimidin–4–yl]thio} acetamide as promising anticonvulsant. Res Results Pharmacol. 2020;6(2):27-41. Shipp A, Lawrence G, Gentry R, McDonald T, Bartow H, Bounds J, et al. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects. Crit Rev Toxicol. 2006;36(6-7):481-608.